Clinical Trial Update: EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating genotypes using intravitreal aflibercept in macular degeneration has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: University of California, San Diego | Conditions: Macular Degeneration, Wet Macular Degeneration | Phase 4 | Status: COMPLETED | Results posted: 2021-03-25